167 related articles for article (PubMed ID: 35343849)
1. Kidney stone formation in a novel murine model of polycystic kidney disease.
Riddle HAL; Zhang S; Qian F; Williams JC; Stubbs JR; Rowe PSN; Parnell SC
Am J Physiol Renal Physiol; 2022 Jul; 323(1):F59-F68. PubMed ID: 35343849
[TBL] [Abstract][Full Text] [Related]
2. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
3. Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.
Shillingford JM; Shayman JA
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F404-F422. PubMed ID: 36794754
[TBL] [Abstract][Full Text] [Related]
4. Pkd1 inactivation induced in adulthood produces focal cystic disease.
Takakura A; Contrino L; Beck AW; Zhou J
J Am Soc Nephrol; 2008 Dec; 19(12):2351-63. PubMed ID: 18776127
[TBL] [Abstract][Full Text] [Related]
5. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
[TBL] [Abstract][Full Text] [Related]
6. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.
Starremans PG; Li X; Finnerty PE; Guo L; Takakura A; Neilson EG; Zhou J
Kidney Int; 2008 Jun; 73(12):1394-405. PubMed ID: 18385665
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
8. Large deletion of Wdr19 in developing renal tubules disrupts primary ciliogenesis, leading to polycystic kidney disease in mice.
Yu SS; Wang E; Chiang CY; Cheng PH; Yeh YS; Wu YY; Chiou YY; Jiang ST
J Pathol; 2022 May; 257(1):5-16. PubMed ID: 35007346
[TBL] [Abstract][Full Text] [Related]
9. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
Wu G
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
[TBL] [Abstract][Full Text] [Related]
10. Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model.
Meca R; Balbo BE; Ormanji MS; Fonseca JM; Iannuzzi LR; Santana Costa E; Onuchic LF; Heilberg IP
Cell Physiol Biochem; 2019; 52(5):1061-1074. PubMed ID: 30977988
[TBL] [Abstract][Full Text] [Related]
11. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
12. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
14. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ma M; Legué E; Tian X; Somlo S; Liem KF
J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
[TBL] [Abstract][Full Text] [Related]
15. Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.
Stroope A; Radtke B; Huang B; Masyuk T; Torres V; Ritman E; LaRusso N
Am J Pathol; 2010 Mar; 176(3):1282-91. PubMed ID: 20093497
[TBL] [Abstract][Full Text] [Related]
16. Cyst expansion and regression in a mouse model of polycystic kidney disease.
Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ
Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997
[TBL] [Abstract][Full Text] [Related]
17. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
[TBL] [Abstract][Full Text] [Related]
18. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
19. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
[TBL] [Abstract][Full Text] [Related]
20. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.
Shibazaki S; Yu Z; Nishio S; Tian X; Thomson RB; Mitobe M; Louvi A; Velazquez H; Ishibe S; Cantley LG; Igarashi P; Somlo S
Hum Mol Genet; 2008 Jun; 17(11):1505-16. PubMed ID: 18263604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
